enVVeno Medical (NVNO)

• Market cap: $6.56M
• 1 day: -3.85%
• 5 days: -14.53%
• 1 month: -2.34%
• 3 months: -25.48%
• 6 months: -68.39%
• Year to date: -18.37%
• 1 year: -91.91%
• 5 years: -96.03%
• 10 years: -99.78%
• Sector: Healthcare
• Industry: Medical Devices

About: enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.

Employees: 37